Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

A push for more transparency in drug research costs

by Dan Gorenstein Feb 16, 2016
The industry worries it's a step toward price controls.
Drug companies are not only in the spotlight for price setting, but now they may be required to be transparent about R&D spending. 
Kiran Foster/Flickr

How more generics could relieve sky-high drug prices

by Dan Gorenstein Feb 4, 2016
More generics are needed to create competition — but can the FDA approve them fast enough?
With high drug prices, more generics are needed to create competition, but can the FDA is having a hard time keeping up.
NVinacco/Flickr

Survey shows drug price hikes widespread in industry

by Ashley Milne-Tyte Feb 4, 2016
It's not just a few bad players, as Congressional hearing puts drug costs in focus.
Conversations about drug pricing blew up at the end of last year when Martin Shkreli’s Turing Pharmaceuticals raised the price of anti-parasite drug Daraprim to $750 per pill. Big price hikes are turning out to be an industry-wide problem.
PHILIPPE HUGUEN/AFP/Getty Images

Congress turns its attention to high drug prices

by Dan Gorenstein Jan 21, 2016
This may actually lower drug costs.

Congress aims to give some drugmakers a break

by Dan Gorenstein Oct 2, 2015
The push comes even as lawmakers discuss ways to rein in drug prices.